Development and Validation of the Physician Global Assessment of Fingernail Psoriasis (PGA-F)

Spinal Disorders

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable

Rheumatology (Oxford).

Ortolan A, Ramiro S, van Gaalen F, Kvien TK, Landewe RBM, Machado PM, Ruyssen-Witrand A, van Tubergen A, Bastiaenen C, van der Heijde D

doi: 10.1093/rheumatology/keaa241.

PsoriasisPsoriatic Arthritis

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study

J Rheumatol.

Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Scarpa R, Marchesoni A, Taylor WJ, Salvarani C, Kalden J, Lubrano E, Carneiro S, Piga M, Floris A, Desiati F, Flynn JA, D'Angelo S, van Kuijk AWR, Catanoso MG, Caso F, Contu P, Ujfalussy I, Helliwell PS, Mease PJ; for the GRAPPA 3PPsA Study Group

doi: 10.3899/jrheum.171183.

Atopic Dermatitis

The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

J Am Acad Dermatol.

Simpson E, Bissonnette R, Eichenfield LF, Guttman E, King B, Silverberg JI, Beck LA, Bieber T, Reich K, Kabashima K, Seyger M, Siegfried E, Stingl G, Feldman SR, Menter A, van de Kerkhof P, Yosipovitch G, Paul C, Martel P, Dubost-Brama A, Armstrong J, Chavda R, Frey S, Joubert Y, Milutinovic M, Parneix A, Teixeira HD, Lin CY, Sun L, Klekotka P, Nickoloff B, Dutronc Y, Mallbris L, Janes JM, DeLozier AM, Nunes F, Paller AS

doi: 10.1016/j.jaad.2020.04.104.

Vitiligo

Validation of a Patient Global Assessment for extent, severity, and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES)

J Eur Acad Dermatol Venereol.

van Geel N, Uitentuis SE, Zuidgeest M, Wolkerstorfer A, Bekkenk MW, Moock C, Van Goethem C, Verlaeckt E, Smet C, Grine L, Speeckaert R

doi: 10.1111/jdv.16562.

Rheumatoid Arthritis

Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire

Ann Rheum Dis.

Gossec L, Chauvin P, Saraux A, Hudry C, Cukierman G, de Chalus T, Dreuillet C, Saulot V, Tong S, Russo-Marie F, Joubert JM7, Berenbaum F

doi: 10.1136/

Psoriasis

Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Am J Clin Dermatol.

Singh S, Kalb RE, de Jong EMGJ, Shear NH, Lebwohl M, Langholff W, Hopkins L, Srivastava B, Armstrong AW

doi: 10.1007/s40257-

Psoriasis

Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials

JAMA Dermatol.

Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW

doi: 10.1001/jamadermatol.

Psoriasis

Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity

JAMA Dermatol

Carr E, Mahil SK, Brailean A, Dasandi T, Pink AE, Barker JN, Rayner L, Turner MA, Goldsmith K, Smith CH

doi: 10.1001/jamadermatol.2020.5844

Psoriasis

Observer-independent assessment of psoriasis affected area using machine learning

J Eur Acad Dermatol Venereol.

Meienberger N, Anzengruber F, Amruthalingam L, Christen R, Koller T, Maul JT, Pouly M, Djamei V, Navarini AA

doi: 10.1111/jdv.16002.

Related content

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study

The validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis

Validation of a Patient Global Assessment for extent, severity, and impact to define the severity strata for the Self Assessment Vitiligo Extent Score (SA-VES)

Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire

Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials

Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity

Observer-independent assessment of psoriasis affected area using machine learning